NHLBI Specialized Centers of Clinically Oriented Research (SCCOR) for Sickle Cell Disease is sponsored by National Heart, Lung, and Blood Institute (NHLBI/NIH). This opportunity supports mission-aligned projects and measurable outcomes. Application snapshot: target deadline March 15, 2026; published funding information $2,000,000 - $4,000,000; eligibility guidance Universities, HBCUs, medical schools, consortia Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

NHLBI Specialized Centers of Clinically Oriented Research (SCCOR) for Sickle Cell Disease is sponsored by National Heart, Lung, and Blood Institute (NHLBI/NIH). Funds multidisciplinary centers focused on translational research for sickle cell disease, emphasizing clinical applications and health disparities at institutions like HBCUs. Application snapshot: target deadline March 15, 2026; published funding information $2,000,000 - $4,000,000; eligibility guidance Universities, HBCUs, medical schools, consortia Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

NIH Intramural Loan Repayment Program for General Research is sponsored by National Institutes of Health (NIH). Loan repayment for biomedical researchers conducting health-related research at NIH, potentially applicable to health promotion topics. Application snapshot: target deadline March 16, 2026; published funding information Up to $50,000 per year; eligibility guidance Individuals conducting research at NIH intramural, health professionals. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

NIMHD Collaborative Research Project Grants to Understand Health Disparities in SCD (U01) is sponsored by National Institute on Minority Health and Health Disparities (NIMHD/NIH). Supports collaborative projects addressing sickle cell disease health disparities among minority populations, ideal for HBCU-led consortia. Application snapshot: target deadline March 17, 2026; published funding information $500,000 - $1,000,000; eligibility guidance HBCUs, minority-serving institutions, nonprofits, universities Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Alzheimer's Disease Programs Initiative - State and Community Grant Program is sponsored by National Institute on Aging (NIA)/NIH. Supports community programs addressing Alzheimer's disease and related dementias. Application snapshot: target deadline March 17, 2026; published funding information Varies; eligibility guidance State health departments, community organizations, nonprofits, and other entities implementing programs in eligible states and communities. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

NIH R25 Summer Research Education Experience Program is sponsored by National Institutes of Health (NIH). Supports education programs (R25) such as summer research experiences—can target underserved youth in STEM. Application snapshot: target deadline March 17, 2026; published funding information Varies; education project support; eligibility guidance U. S. institutions eligible for NIH grants (universities, nonprofits) Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) is sponsored by National Institutes of Health (NIH). The primary federal funding mechanism for health-related R&D. Application snapshot: target deadline April 5, 2026; published funding information Up to $2,000,000+; eligibility guidance United States small business concerns (SBCs) with 500 or fewer employees performing innovative R&D. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

PHS 2025-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) is sponsored by National Institutes of Health (NIH). This flagship program provides non-dilutive funding to small businesses to support the research and development of innovative biomedical technologies, including novel therapeutics and drug delivery systems.

PHS 2025-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications is sponsored by National Institutes of Health (NIH). Supports small businesses in developing innovative healthcare technologies. Application snapshot: target deadline April 5, 2026; published funding information Up to $300,000 (Phase I); eligibility guidance U. S. small business concerns (SBCs) with 500 or fewer employees. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

PHS 2025-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH). This opportunity supports mission-aligned projects and measurable outcomes. Application snapshot: target deadline April 5, 2026; published funding information $150,000 - $2,000,000; eligibility guidance United States Small Business Concerns (SBCs) Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

PHS 2025-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH). This omnibus solicitation supports small businesses in developing innovative technologies with high commercial potential, including medical devices specifically designed for pediatric populations. Application snapshot: target deadline April 5, 2026; published funding information $150,000 - $2,000,000; eligibility guidance United States Small Business Concerns (SBCs) Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

NIH SBIR/STTR Omnibus Solicitation (Parent R43/R44 and R41/R42) is sponsored by National Institutes of Health (NIH). The primary federal vehicle for funding small business medical technology development, supporting feasibility (Phase I) and full R&D (Phase II) across all health domains. This investigator-initiated program covers everything from diagnostics to medical devices and therapeutics.

PHS 2025-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH). Application snapshot: target deadline April 5, 2026; published funding information $150,000 - $2,000,000; eligibility guidance United States Small Business Concerns (SBCs) Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying. United States Small Business Concerns (SBCs) Frequently Asked Questions Who can apply for PHS 2025-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)? Based on current listing details, eligibility includes: United States Small Business Concerns (SBCs) Applicants should confirm final requirements in the official notice before submission. What is the typical funding level for PHS 2025-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)? Current published award information indicates $150,000 - $2,000,000 Always Application snapshot: target deadline April 5, 2026; published funding information $306,204 - $1,000,000; eligibility guidance Small Businesses / For-profit entities Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (F33) is sponsored by National Institutes of Health (NIH). Supports experienced scientists who wish to make major changes in the direction of their research careers or to broaden their scientific background by acquiring new research capabilities. Application snapshot: target deadline April 8, 2026; published funding information Varies by career level; eligibility guidance Individual investigators with at least seven years of relevant research or professional experience after the doctoral degree. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Ruth L. Kirschstein National Research Service Award (F32) – Individual Postdoctoral Fellowship is sponsored by National Institute of Mental Health (NIMH) / NIH. This opportunity supports mission-aligned projects and measurable outcomes. Application snapshot: target deadline April 8, 2026; published funding information Varies by stipend level; eligibility guidance U. S. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) is sponsored by National Institutes of Health (NIH). This opportunity supports mission-aligned projects and measurable outcomes. Application snapshot: target deadline April 8, 2026; published funding information $28,224 (plus tuition/fees); eligibility guidance Individual graduate students enrolled in a PhD or equivalent research degree program who are U. S. citizens or permanent residents. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is sponsored by National Institutes of Health (NIH). Provides mentored research training for promising postdoctoral candidates to develop as independent investigators in scientific health-related fields relevant to NIBIB's mission, including imaging and bioengineering. Application snapshot: target deadline April 8, 2026; published funding information Stipend, tuition, and institutional allowance (standard NRSA rates); eligibility guidance Postdoctoral researchers who are U. S. citizens, non-citizen nationals, or permanent residents. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

NIH Ruth L. Kirschstein NRSA Individual Predoctoral Fellowship (F31) is sponsored by National Institutes of Health (NIH). Supports promising predoctoral students with potential to develop into productive, independent research scientists in health-related fields. Application snapshot: target deadline April 8, 2026; published funding information $28,000+ Stipend; eligibility guidance Individual predoctoral students at a domestic institution (like WVU or Marshall) pursuing a PhD or equivalent research degree. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) is sponsored by National Institutes of Health (NIH). Supports promising predoctoral students to obtain individualized, mentored research training from faculty sponsors while conducting research in scientific health-related fields relevant to the NIH mission. Application snapshot: target deadline April 8, 2026; published funding information $28,224 (plus tuition/fees); eligibility guidance Individual graduate students enrolled in a PhD or equivalent research degree program who are U.S. citizens or permanent residents. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is sponsored by National Institutes of Health (NIH). This fellowship supports the research training of promising postdoctoral candidates who have the potential to become productive, independent investigators in health-related fields, including health promotion and disease prevention. Application snapshot: target deadline April 8, 2026; published funding information $61,008 - $74,000; eligibility guidance Individuals with a research or professional doctoral degree (PhD, MD, etc.) who are U.S. citizens or permanent residents. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Pilot Grant – Sickle Cell Disease Pain Analgesia & Integrative Network (SCDPAIN) U24 is sponsored by SCDPAIN (University of California, Irvine, NIH-supported). Supports interdisciplinary pilot research on pain mechanisms and complementary and integrative health interventions in sickle cell disease—particularly relevant to mechanistic signaling. Application snapshot: target deadline April 20, 2026; published funding information Not specified (pilot grant, likely modest NIH-level funding); eligibility guidance New or established investigators; academic/research institutions. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Advancing Nutrition-related Research Across the Lifespan is sponsored by National Institute of Nursing Research (NINR), NIH. This upcoming funding opportunity will solicit applications for research examining social determinants of health (SDOH) to improve nutrition-related health outcomes and reduce related health disparities across the lifespan, particularly in vulnerable populations. Application snapshot: target deadline April 27, 2026; published funding information Unspecified; eligibility guidance Government entities (Federally recognized Native American tribal governments, state governments, etc.) Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Advancing Nutrition‑related Research Across the Lifespan is sponsored by NIH (NINR with other ICOs). Solicits research on nutrition-related health outcomes across lifespan; AI methods not explicit but may be applicable if included in proposed research. Application snapshot: target deadline April 27, 2026; published funding information Not yet specified; eligibility guidance Public and private institutions of higher education Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Notice of Special Interest (NOSI): Encouraging Women's Health Research within the NIDCD Mission Areas is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD) / National Institutes of Health (NIH). This opportunity supports mission-aligned projects and measurable outcomes. Application snapshot: target deadline May 5, 2026; published funding information See official notice; eligibility guidance Applicants should refer to the specific NIH funding opportunity announcement for full eligibility details, as this is a Notice of Special Interest (NOSI) that encourages research within existing NIH grant mechanisms. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Notice of Special Interest: Encouraging Women’s Health Research within the NIDCD Mission Areas is sponsored by NIH (National Institute on Deafness and Other Communication Disorders). Solicits applications to improve women’s health across the lifespan within NIDCD’s mission areas. Application snapshot: target deadline May 5, 2026; published funding information See official notice; eligibility guidance Researchers eligible under NIDCD grant mechanisms. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Early Immune System Development and Ontogency (R01 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). This opportunity supports mission-aligned projects and measurable outcomes. Application snapshot: target deadline May 7, 2026; published funding information $250,000 - $500,000 per year (est.); eligibility guidance Universities, research institutions, public/state/private institutions including universities Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

NIDDK Initiative for Diversity Research at HBCUs (R01 Clinical Trial Not Allowed) (PAR-25-045) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH). Supports diabetes, kidney, digestive, and hematologic disease research (including sickle cell) at HBCUs to build research capacity and address health disparities. Application snapshot: target deadline May 7, 2026; published funding information $250,000 - $500,000; eligibility guidance HBCUs; research institutions designated as Historically Black Colleges and Universities Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Early Immune System Development and Ontogency (R01 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). Supports research elucidating mechanisms of early immune development in utero, postnatal period, and early childhood, including in neonates with or without HIV/ART exposure, focusing on immune cells at maternal-fetal interface and T/B cell maturation.

ORACLE 3C: Chronic Conditions, Coinfections, and Comorbidities in HIV (PAR-26-105) is sponsored by National Institutes of Health (NIH). This opportunity supports mission-aligned projects and measurable outcomes. Application snapshot: target deadline May 7, 2026; published funding information $500,000+; eligibility guidance Higher education institutions, nonprofits, and public/state controlled institutions of higher education. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01) is sponsored by National Institutes of Health (NIH/NIDA). This opportunity supports mission-aligned projects and measurable outcomes. Application snapshot: target deadline May 7, 2026; published funding information Varies (based on scope); eligibility guidance Public and private institutions of higher education, nonprofits, and small businesses. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.